Headache Diary for Migraine Patients
Use of a Headache Calendar/Journal in Patients Who Have Migraine
1 other identifier
interventional
50
1 country
1
Brief Summary
Use of a headache journal/calendar in patients who have migraine to ascertain if keeping a headache journal affects the quality of life and the headache burden.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 14, 2025
CompletedFirst Submitted
Initial submission to the registry
July 7, 2026
CompletedFirst Posted
Study publicly available on registry
July 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2029
July 20, 2026
July 1, 2026
3.5 years
July 7, 2026
July 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Migraine Specific Quality of Life
Migraine Specific Quality of Life using the MSQv2.1, a 14-item validated assessment used to measure how migraines affect a patient's daily functioning and well-being. Each of the 14 questions is scored using a 6-point scale ranging from 1 ("Always") to 6 ("Never"). The raw scores for each of the three domains are transformed into a standardized 0 to 100 scale, where higher scores indicate a better quality of life (less impact/disability from migraine).
Baseline, 4 weeks, 8 weeks, 12 weeks, and 24 weeks
Secondary Outcomes (1)
Migraine Disability Assessment (MIDAS) score
Baseline, 4 weeks, 8 weeks, 12 weeks, and 24 weeks
Study Arms (1)
Headache diary
EXPERIMENTALVirtual headache calendar/journal is given to migraine patients to see if it affects their migraine burden. Surveys are completed virtually at baseline, 4 weeks, 8 weeks, 12 weeks, and 24 weeks.
Interventions
Eligibility Criteria
You may qualify if:
- Adults diagnosed with migraine (episodic or chronic) according to ICHD-3 criteria, with at least 3 months of confirmed diagnosis. Both episodic migraine (≤14 headache days/month) and chronic migraine (≥15 headache days/month) are eligible and will be recorded as a demographic subgroup variable.
You may not qualify if:
- Individuals under the age of 18
- Non-English speaking individuals
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hackensack Meridian Health - JFK Medical Center
Edison, New Jersey, 08820, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brian Gerhardstein, MD, MPH
Hackensack Meridian Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 7, 2026
First Posted
July 13, 2026
Study Start
January 14, 2025
Primary Completion (Estimated)
August 1, 2028
Study Completion (Estimated)
August 1, 2029
Last Updated
July 20, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share